Genetic Disorder Clinical Trials

11 recruitingLast updated: May 13, 2026

There are 11 actively recruiting genetic disorder clinical trials across 7 countries. Studies span Not Applicable, Phase 2. Top locations include Pittsburgh, Pennsylvania, United States, Philadelphia, Pennsylvania, United States, Bethesda, Maryland, United States. Updated daily from ClinicalTrials.gov.


Genetic Disorder Trials at a Glance

11 actively recruiting trials for genetic disorder are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Pittsburgh, Philadelphia, and Bethesda. Lead sponsors running genetic disorder studies include Columbia University, Federal University of São Paulo, and Bahçeşehir University.

Browse genetic disorder trials by phase

Treatments under study

About Genetic Disorder Clinical Trials

Looking for clinical trials for Genetic Disorder? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Genetic Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Genetic Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Inherited Reproductive Disorders

InfertilityHypogonadismAmenorrhea+1 more
National Institute of Environmental Health Sciences (NIEHS)850 enrolled2 locationsNCT01500447
Recruiting

Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders

Traumatic Brain Injury (TBI)Hypoxic-ischemic encephalopathy (HIE)Williams Syndrome+20 more
Healing Hope International100 enrolled1 locationNCT07493096
Recruiting

Neurogenetics Patient Registry

Neurogenetic Disorders
University of Pittsburgh1,000 enrolled1 locationNCT02995538
Recruiting

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Mitochondrial DiseasesMitochondrial DisordersMitochondrial Genetic Disorders+2 more
Columbia University1,000 enrolled17 locationsNCT01694940
Recruiting

The Relationship Between Functional Independence and Family Well-being in Children With Rare Genetic Disorders

Quality of LifeRare Genetic DisordersFunctional Impairment
Bahçeşehir University45 enrolled1 locationNCT07348926
Recruiting

Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops

Nonimmune Fetal HydropsNonimmune Hydrops in NeonateGenetic disorders
Thomas Jefferson University55 enrolled1 locationNCT03911531
Recruiting
Not Applicable

Pediatric Neurogenetic Diagnosis Support Platform

Genetic DiseaseNeurogenetic Disorders
Universidad Nacional Andres Bello9 enrolled1 locationNCT06725901
Recruiting

Self-harm Behaviour Among the Most At-risk Adolescents

Non Suicidal Self InjurySelf-harmEpigenetic Disorder+3 more
University of Ljubljana, Faculty of Medicine400 enrolled2 locationsNCT05765864
Recruiting

Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART

CardiologyGenetic DiseaseCardiac Disease+2 more
University Hospital of Ferrara200 enrolled1 locationNCT06898307
Recruiting
Phase 2

PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)

Coronary DiseaseBleedingCoronary Artery Disease+5 more
Federal University of São Paulo120 enrolled1 locationNCT06542393
Recruiting

Lipid Transport Disorder Italian Genetic Record (LIPIGEN)

Familial HypercholesterolemiaGenetic Disorder
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)10,000 enrolled1 locationNCT06362473